Different activation of NF-κB by stimulation of dopamine D2L and D2S receptors through calcineurin activation

Journal of Neurochemistry

Volumn 90, Issue 1, 2004, Pages 155-163

  Takeuchi, Yusuke ^a   Fukunaga, Kohji ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Calcineurin; Cyclosporin A; DARPP 32; Dopamine D2 receptor; NF B

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CALCIUM ION; CRE RECOMBINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLOSPORIN A; DOPAMINE 2 RECEPTOR; FORSKOLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; LUCIFERASE; PHOSPHOPROTEIN DARPP 32; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE (CALCIUM,CALMODULIN);

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DEPHOSPHORYLATION; ENZYME ACTIVATION; ISOMER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; RAT; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; CALCINEURIN; CALCIUM; CELL LINE; CYCLOSPORINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; ENZYME INHIBITORS; FORSKOLIN; GENE EXPRESSION REGULATION; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE TISSUE PROTEINS; NF-KAPPA B; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN ISOFORMS; RATS; RECEPTORS, DOPAMINE D2; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSFECTION;

ANIMALIA;

EID: 3042770552     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02476.x     Document Type: Article

References (48)

1. Biswas G., Anandatheerthavarada H. K., Zaidi M. and Avadhani N. G. (2003) Mitochondria to nucleus stress signaling: a distinctive mechanism of NFκB/Rel activation through calcineurin-mediated inactivation of IκBβ. J. Cell Biol. 161, 507-519.
2. Bouwmeester T., Bauch A., Ruffner H. et al. (2004) A physical and functional map of the human TNF-α/NF-κB signal transduction pathway. Nat. Cell Biol. 6, 97-105.
3. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. 2 receptors. Biochem. Biophys. Res. Commun. 256, 33-40.
5. 2 receptor: two molecular forms generated by alternative splicing. EMBO J. 8, 4025-4034.
6. 1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture. Synapse 25, 227-233.
7. Davis K. L., Kahn R. S., Ko G. and Davidson M. (1991) Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 148, 1474-1486.
8. Dhawan P. and Richmond A. (2002) A novel NF-κB-inducing kinase-MAPK signaling pathway up-regulates NF-κB activity in melanoma cells. J. Biol. Chem. 277, 7920-7928.
9. Enjalbert A., Guillon G., Mouillac B., Audinot V., Rosolonjanahary R., Kordon C. and Bockaert J. (1990) Dual mechanisms of inhibition by dopamine of basal and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells. J. Biol. Chem. 265, 18816-18822.
10. 2+/calcineurin signalling in cells of the immune system. Biochem. Biophys. Res. Commun. 311, 1117-1132.
11. Fridmacher V., Kaltschmidt B., Goudeau B., Ndiaye D., Rossi F. M., Pfeiffer J., Kaltschmidt C., Israel A. and Memet S. (2003) Forebrain-specific neuronal inhibition of nuclear factor-κB activity leads to loss of neuroprotection. J. Neurosci. 23, 9403-9408.
12. Ghahremani M. H., Cheng P., Lembo P. M. C. and Albert P. R. (1999) Distinct roles for Gai2, Gai3 and Gbg in modulation of forskolin- or Gs-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors. J. Biol. Chem. 274, 9238-9245.
13. 2 dopamine receptor isoforms. Nature 342, 923-926.
14. Groth R. D., Dunbar R. L. and Mermelstein P. G. (2003) Calcineurin regulation of neuronal plasticity. Biochem. Biophys. Res. Commun. 311, 1159-1171.
15. Hemmings H. C. Jr, Greengard P., Tung H. Y. and Cohen P. (1984b) DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310, 503-505.
16. Hemmings H. C. Jr, Nairn A. C., Aswad D. W. and Greengard P. (1984a) DARPP-32, a dopamine- and adenosine 3′: 5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus. J. Neurosci. 4, 99-110.
17. Higashida H., Streaty R. A., Klee W. and Nirenberg M. (1986) Bradykinin-activated transmembrane signals are coupled via No or Ni to production of inositol 1,4,5-trisphosphate, a second messenger in NG108-15 neuroblastoma-glioma hybrid cells. Proc. Natl Acad. Sci. USA 83, 942-946.
18. 5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines. J. Recept. Res. 13, 79-94.
19. Jackson D. M. and Westlind-Danielsson A. (1994) Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol. Ther 64, 291-370.
20. 2+/calmodulin-dependent protein phosphatase calcineurin mediates the expression of iNOS through IKK and NF-κB activity in LPS-stimulated mouse peritoneal macrophages and RAW 264.7 cells. Biochem. Biophys. Res. Commun. 314, 695-703.
21. Laemmli U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
22. Lilienbaum A. and Israel A. (2003) From calcium to NF-κB signaling pathways in neurons. Mol. Cell Biol. 23, 2680-2698.
23. 2 receptor subtypes to protein kinase C. J. Neurochem. 59, 2311-2317.
24. 2L glioma cells. J. Neurochem. 71, 980-990.
25. Mattson M. P., Culmsee C., Yu Z. and Camandola S. (2000) Roles of nuclear factor κB in neuronal survival and plasticity. J. Neurochem. 74, 443-456.
26. Meffert M. K., Chang J. M., Wiltgen B. J., Fanselow M. S. and Baltimore D. (2003) NF-κB functions in synaptic signaling and behavior. Nat. Neurosci. 6, 1072-1078.
27. Missale C., Nash R., Robinson S. W., Jaber M. and Caron M. G. (1998) Dopamine receptors from structure to function. Physiol. Rev. 78, 189-225.
28. Miyakawa T., Leiter L. M., Gerber D. J., Gainetdinov R. R., Sotnikova T. D., Zeng H., Caron M. G. and Tonegawa S. (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl Acad. Sci. USA 100, 8987-8992.
29. 2 dopamine receptors produced by alternative RNA splicing. Nature 342, 21-28.
30. Nishi A., Snyder G. L. and Greengard P. (1997) Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J. Neurosci. 17, 8147-8155.
31. Nishi A., Snyder G. L., Naim A. C. and Greengard P. (1999) Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. J. Neurochem. 72, 2015-2021.
32. 2L receptor stimulation of the mitogen-activated protein kinase pathway is dependent on trans-activation of the platelet-derived growth factor receptor. Mol. Pharmacol. 60, 92-103.
33. Ouimet C. C., Miller P. E., Hemmings H. C. Jr, Walaas S. I. and Greengard P. (1984) DARPP-32, a dopamine- and adenosine 3′: 5′-monophosphate- regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4, 111-124.
34. Rusnak F. and Mertz P. (2000) Calcineurin: form and function. Physiol. Rev. 80, 1483-1521.
35. 1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 22, 947-950.
36. Takeuchi Y. and Fukunaga K. (2003a) Differential regulation of NF-κB, SRE and CRE by dopamine D1 and D2 receptors in transfected NG108-15 cells. J. Neurochem. 85, 729-739.
37. Takeuchi Y. and Fukunaga K. (2003b) Differential subcellular localization of two dopamine D2 receptor isoforms in transfected NG108-15 cells. J. Neurochem. 85, 1064-1074.
38. Takeuchi Y. and Fukunaga K. (2004) Different effects of five dopamine receptor subtypes on nuclear factor-κB activity in NG108-15 cells and mouse brain. J. Neurochem. 88, 41-50.
39. 2+/calmodulin-dependent protein kinase II and brain-derived neurotrophic factor gene expression by stimulation of dopamine D2 receptor in transfected NG108-15 cells. J. Neurochem. 82, 316-328.
40. Towbin H., Staehelin T. and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76, 4350-4354.
41. Trushin S. A., Pennington K. N., Algeciras-Schimnich A. and Paya C. V. (1999) Protein kinase C and calcineurin synergize to activate IκB kinase and NF-κB in T lymphocytes. J. Biol. Chem. 274, 22923-22931.
42. 4Cl cells. J. Biol. Chem. 265, 10320-10326.
43. Walaas S. I. and Greengard P. (1984) DARPP-32, a dopamine- and adenosine 3′: 5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J. Neurosci. 4, 84-98.
44. Walaas S. I., Aswad D. W. and Greengard P. (1983) A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 301, 69-71.
45. Weinberger D. R. and Lipska B. K. (1995) Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res. 16, 87-110.
46. Whitmarsh A. J., Shore P., Sharrocks A. D. and Davis R. J. (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science 269, 403-407.
47. Yang M., Zhang H., Voyno-Yasenetskaya T. and Ye R. D. (2003) Requirement of Gbetagamma and c-Src in D2 dopamine receptor-mediated nuclear factor-κB activation. Mol. Pharmacol. 64, 447-455.
48. 4MN9D cells. Mol. Pharmacol. 60, 857-864.